 | |
| Type | Private |
|---|---|
| Industry | Pharmaceutical |
| Founded | 2000 (as National Healthcare Technology), reestablished in 2009 |
| Headquarters | Irvine, California, U.S. |
Key people |
Raymond C. Dabney (President, CEO, Co-Founder and Director) Robert Melamede (Co-Founder) |
| Products | Pharmaceutical products |
| Website | cannabisscience |
Cannabis Science, Inc. is a biotech company based in Irvine, California. The company was incorporated in 2009 and formerly traded under the ticker CBIS on the Over-The-Counter Bulletin Board until October 2019, when their SEC license was revoked.
The company's stated goal was to obtain Food and Drug Administration (FDA) approval for cannabis-based medicines, with a focus on treating skin cancer (basal and squamous cell carcinomas),posttraumatic stress disorder and HIV. The FDA has not approved these treatments.